최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of lipid research, v.50 suppl., 2009년, pp.S412 - S416
Erickson, Sandra K.
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States and, indeed, worldwide. It has become a global public health issue. In the United States, the prevalence in the general population is estimated at approximately 20%, while that in the morbidly obese popula...
Mayo Clin. Proc. Ludwig 55 434 1980 Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
Semin. Liver Dis. Lazo 28 339 2008 10.1055/s-0028-1091978 The epidemiology of nonalcoholic fatty liver disease: a global perspective
Clin. Liver Dis. Ong 11 1 2007 10.1016/j.cld.2007.02.009 Epidemiology and natural history of NAFLD and NASH
Hepatology. Marrero 36 1349 2002 10.1002/hep.1840360609 NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
J. Hepatol. Bullock 41 685 2004 10.1016/j.jhep.2004.05.008 Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma
Semin. Liver Dis. Chitturi 21 27 2001 10.1055/s-2001-12927 Etiopathogenesis of nonalcoholic steatohepatitis
J. Clin. Endocrinol. Metab. Utzschneider 91 4753 2006 10.1210/jc.2006-0587 Review: the role of insulin resistance in nonalcoholic fatty liver disease
Semin. Liver Dis. Ramesh 24 399 2004 10.1055/s-2004-860869 Hepatitis C and nonalcoholic fatty liver disease
Clin. Infect. Dis. Guaraldi 47 250 2008 10.1086/589294 Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors
Curr. HIV/AIDS Rep. Merriman 3 113 2006 10.1007/BF02696654 Nonalcoholic fatty liver disease and HIV infection
Diabetes Care. Targher 29 1325 2006 10.2337/dc06-0135 Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease
Dig. Dis. Sci. Aygun 53 1352 2008 10.1007/s10620-007-9998-7 Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease
Semin. Liver Dis. Rubinstein 28 380 2008 10.1055/s-0028-1091982 Hepatic, cardiovascular and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease
J. Hepatol. Ong 49 608 2008 10.1016/j.jhep.2008.06.018 Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Am. J. Gastroenterol. Dunn 103 2263 2008 10.1111/j.1572-0241.2008.02034.x Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study
Gastroenterology. Ratziu 128 1898 2005 10.1053/j.gastro.2005.03.084 Sampling variability of liver biopsy in nonalcoholic fatty liver disease
Am. J. Clin. Pathol. Yeh 128 837 2007 10.1309/RTPM1PY6YGBL2G2R Pathology of nonalcoholic fatty liver disease
Hepatology. Merriman 44 874 2006 10.1002/hep.21346 Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
Hepatology. Angulo 45 846 2007 10.1002/hep.21496 The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD
J. Gastrointestin. Liver Dis. Munteanu 17 187 2008 Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: Fibro Test-Fibro-Max™ Experience
Semin. Liver Dis. Wieckowska 28 386 2008 10.1055/s-0028-1091983 Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive
Hepatology. Mofrad 37 1286 2003 10.1053/jhep.2003.50229 Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
Semin. Liver Dis. Schwimmer 27 312 2007 10.1055/s-2007-985075 Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents
J. Clin. Endocrinol. Metab. Kershaw 89 2548 2004 10.1210/jc.2004-0395 Adipose tissue as an endocrine organ
Hepatology. Maher 48 670 2008 10.1002/hep.22399 Beyond insulin resistance: innate immunity in nonalcoholic steatohepatitis
Semin. Liver Dis. Jou 28 370 2008 10.1055/s-0028-1091981 Mechanisms of disease progression in nonalcoholic fatty liver disease
Am. J. Gastroenterol. Willner 96 2957 2001 10.1111/j.1572-0241.2001.04667.x Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency and severity of disease
Am. J. Med. Struben 108 9 2000 10.1016/S0002-9343(99)00315-0 Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds
Ann. Hepatol. Osterreicher 6 83 2007 10.1016/S1665-2681(19)31936-2 The genetics of nonalcoholic fatty liver disease
Am. J. Gastroenterol. Caldwell 97 1496 2002 10.1111/j.1572-0241.2002.05795.x Is NASH underdiagnosed among African Americans?
Hepatology. Browning 40 1387 2004 10.1002/hep.20466 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
Am. J. Gastroenterol. Browning 99 292 2004 10.1111/j.1572-0241.2004.04059.x Ethnic differences in the prevalence of cryptogenic cirrhosis
Hepatology. Weston 41 372 2005 10.1002/hep.20554 Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease
Proc. Natl. Acad. Sci. USA. Petersen 103 18273 2006 10.1073/pnas.0608537103 Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
J. Gastroenterol. Hepatol. Amarapurkar 22 788 2007 10.1111/j.1440-1746.2007.05042.x How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
J. Gastroenterol. Hepatol. Fan 22 794 2007 10.1111/j.1440-1746.2007.04952.x What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Nat. Genet. Romeo 40 1461 2008 10.1038/ng.257 Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Hepatology. Musso 47 1167 2008 10.1002/hep.22142 Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH
J. Hepatol. Solga 38 681 2003 10.1016/S0168-8278(03)00097-7 Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics
Int. J. Exp. Pathol. Anstee 87 1 2006 10.1111/j.0959-9673.2006.00465.x Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
Semin. Liver Dis. Rafiq 28 427 2008 10.1055/s-0028-1091986 Effects of weight loss on nonalcoholic fatty liver disease
Am. J. Clin. Nutr. Zivkovic 86 285 2007 10.1093/ajcn/86.2.285 Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Semin. Liver Dis. Verna 28 407 2008 10.1055/s-0028-1091985 Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery
Hepatology. Browning 44 466 2006 10.1002/hep.21248 Statins and hepatic steatosis: perspectives from the Dallas Heart Study
Gastroenterology. Ratziu 135 100 2008 10.1053/j.gastro.2008.03.078 Rosiglitazone for nonalcoholic steatohepatitis: one year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial
Gastroenterology. Guruprasad 135 1176 2008 10.1053/j.gastro.2008.06.047 Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Semin. Liver Dis. Kashi 28 396 2008 10.1055/s-0028-1091984 Current and emerging therapies in nonalcoholic fatty liver disease
Hepatology. Bellentani 47 746 2008 10.1002/hep.22009 Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.